HRS-9231

N/A

Report date: 2025/11/14 20:00:34
NME

Base Information

Drug NameHRS-9231
Drug Alias NameHRS-9231HRS9231
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsUpdating
Therapy Area/IndicationsContrast agentsCentral Nervous System InjuryPeripheral Vascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Suncadia Medicine Co LtdJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Suncadia Medicine Co LtdJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsContrast agentsCentral Nervous System InjuryPeripheral Vascular Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A